A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better ...

Shares of Novo Nordisk ended higher on Monday and extended gains in after-hours trading, while "Big Pharma" rival Eli Lilly ...

The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as ...

The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...

Telehealth company Ro will offer single-dose vials of Eli ... and weight management. Latterly, it has also started to offer compounded versions of Novo Nordisk's GLP-1 agonist drug semaglutide ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.

Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...

NICE has recommended Lilly’s new soft tissue sarcoma treatment Lartruvo for use on the NHS, only the second drug to be funded ... Patient groups have joined the company in heralding the ...

The singer reflected on being ‘so broken and dark’ a year ago.